Study Period News Today

A study in the Journal of the American Academy of Child and Adolescent Psychiatry found that girls and boys were affected differently by the pandemic. The study focused on depressive symptoms among 16-year-olds surveyed during the pandemic compared to those surveyed pre-pandemic.

Thinking of getting a tummy tuck in the new year? The procedure has remained very safe, a new 16-year analysis shows, with many patients opting for a little liposuction at the same time.

The data, published in the journal JAMA, showed patients who were obese and without diabetes experienced a 14% weight regain nearly a year after they switched to a placebo from an eight-month course of Lilly's Zepbound. Meanwhile, those who continued the treatment experienced an additional 5.5% weight reduction during the 52-week period, data from the study showed. Shares of Eli Lilly fell over 4% in morning trading.

"DDR Defective Tumors Market"DelveInsight's "DDR Defective Tumors Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the DDR Defective Tumors, historical and forecasted

Shrinkage of one of the brain's key memory centers appears to herald thinking declines, a new study finds.

New York, USA, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Idiopathic Pulmonary Fibrosis Market to Show Immense Growth at a CAGR of 6.6% During the Study Period (2019–2032) | DelveInsight The overall market of

The overall market of idiopathic pulmonary fibrosis is expected to rise due to increasing prevalent cases over the globe and thus the surge in treatment options. The expected launch of emerging therapy for idiopathic pulmonary fibrosis treatment, will boost the idiopathic pulmonary fibrosis market in the forecasted period (2023–2032).New York, USA, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Idiopathic Pulmonary Fibrosis Market to Show Immense Growth at a CAGR of 6.6% During the Study Period (2019&...

The increasing diagnosed prevalence, and the development of well-designed, randomized, controlled non-crossover trials with the potential benefits for RVO patients will drive the retinal vein occlusion market growth in the forecast period (2023–2032).New York, USA, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Retinal Vein Occlusion Market to Exhibit Considerable Growth at a CAGR of ~6% During the Study Period (2019–2032) | DelveInsight The increasing diagnosed prevalence, and the development ...

New York, USA, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Retinal Vein Occlusion Market to Exhibit Considerable Growth at a CAGR of ~6% During the Study Period (2019–2032) | DelveInsight The increasing diagnosed

New York, USA, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Frontotemporal Dementia Treatment Drug Market to Showcase Immense Growth During the Study Period (2019–2032) | DelveInsight The overall frontotemporal dementia